搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Knowridge
6 天
Widely used blood pressure drugs linked to heart failure
A recent study from the University of Bologna, published in the journal Hypertension, has uncovered an important finding ...
8 天
on MSN
Common heart drug may slow progression of Huntington's disease
A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa ...
Frontiers
1 天
New Frontiers in Heart Failure Therapy: Mechanisms, Efficacy, and Challenges
Advances in cardiovascular pharmacology have significantly enhanced patient outcomes through a new wave of medications ranging from anticoagulants and antiplatelet agents to lipid-lowering drugs and ...
Knowridge
12 天
This type of blood pressure drug may raise heart disease risk for women
Beta-blockers are a commonly prescribed medication for managing high blood pressure, which is a leading risk factor for heart ...
Daily
4 天
Expert Panel Reaffirms Beta-blockers as First-Line Therapy for Hypertension in India
India: An expert panel in India came together to develop a consensus on the role of beta-blockers in managing hypertension.
Sydney Morning Herald
11 天
Algorae cardiovascular drug betters beta-blockers in studies
The company conducted preclinical assessments at the Monash University Victorian Heart Institute Research Laboratories to ...
Verywell Health on MSN
9 天
Heart Attack Medication for Prevention and Ongoing Management
Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...
7 天
Common heart drug shows promise for Huntington’s disease
Common symptoms of Huntington's include uncontrolled movements like jerking and twitching, loss of coordination, difficulty ...
AFP
13 天
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial ...
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈